14:15 01-10-2014
MAIN Russian
About us On-line subscription
KazakhstanTajikistanUzbekistanKyrgyzstanTurkmenistanWorld
POLITICSBUSINESSINCIDENTSSOCIETYCULTURESPORTANALYSISSCIENCE
Drug to crack resistant TB

Bishkek (AKIpress) - doctor-x-ray Florian von Groote-Bidlingmaier, medical director of TASK Applied Science, a research unit collaborating with Stellenbosch University, told doctors yesterday about trials of new drugs that might offer a lifeline to patients with drug-resistant TB, Times Live reported.

He was speaking at the World TB Day Symposium, convened by the National Institute for Communicable Diseases, in Johannesburg.

Half-a-million South Africans contract TB every year and one in 25 is likely to develop a form of the disease resistant to treatment. Drug-resistant TB kills at least one in five of the people who contract it.

Most TB drugs have been in use for at least 50 years, Von Groote-Bidlingmaier said, but the development of a new medicine took many years and could cost as much as 10 billion rand ($920.3 million).

It can be years before patients gain access to a new medicine. For example, the drug bedaquiline was developed in 2005 but almost 10 years later it is available to only 200 patients in South Africa in a monitored program with strict eligibility criteria.

Von Groote-Bidlingmaier said that delamanid, conditionally approved by the European Medicines Agency recently, was being tested at three sites in South Africa and abroad. The current trials, if successful, are the last step before the drug is registered.

“TB is not treated with a single drug. There is a need for further trials to test new drugs in combination to see if we can find a better treatment regimen.”

South Africa is the world leader in the exploitation of the GeneXpert machine to detect TB much more quickly. But a study has shown that, though detection has improved, patients are no more likely to start and see their treatment through to completion.

TASK Applied Science performs clinical trials in tuberculosis (TB) in Cape Town, South Africa. TASK can provide assistance to efficiently conduct studies for diagnosis, treatment or prevention of tuberculosis.


Twitterfacebookprint
13:01 25.03.2014
LATEST NEWS
14:04 Kazakhstani delegation attends inauguration of Afghan president-elect Ghani13:41 IV Turkmen-German Health Forum starts in Ashgabat13:23 Norway best for older people, Global AgeWatch Index finds13:14 Construction of hydropower plants in Kyrgyzstan to ensure reasonable use of water resources in region – Foreign Minister13:10 Kyrgyzstani wins MMA tournament in Moscow on 23rd second13:07 Asian Games 2014: Kazakh female boxer brings 17th silver for team13:06 Withdrawal of ISAF troops from Afghanistan to cause escalation of chaos in country – Tajik Interior Minister12:50 U.S. signs pact to keep troops in Afghanistan past 201412:41 National Bank spends $290 million for foreign currency interventions in 201412:40 Kyrgyzstan ranks 27th in medal standings at Asian Games12:31 Japanese Government to allocate over a thousand sets of school equipment to educational establishments of Moskovsky district worth $110 thousand12:21 Kazakh Parliament ratifies agreement with Russia on order of stay of citizens12:21 Tajikistan takes 61st place in Global AgeWatch ranking12:08 Kazakh Parliament ratifies Technical Cooperation Trust Fund agreement with UN11:53 So-called OBON keeps down Kyrgyzstan's development – MP Madylbekov11:52 Uzbekistan, Turkmenistan hold political consultations in Tashkent11:47 Hong Kong democracy protesters still on rally on National Day11:35 Kazakh Parliament ratifies good-neighborliness agreement with Russia11:27 $102 million to be allocated for tourism development in Kashkadarya region11:26 Exhibition on Japanese Photography from 1970s to Present to take place in Bishkek
Astana
+11° C
Ashgabat
+26° C
Bishkek
+19° C
Dushanbe
+29° C
Tashkent
+25° C
exchange rates
 
68.89
54.40
8.82
1.38
229.74
181.90
29.63
4.62
6.33
5.00
0.81
0.13
3122.57
2363.47
385.06
61.53
3.59
2.85
0.46
0.07

© AKIpress News Agency - 2001-2014
Use of the AKIpress.com materials must be accompanied by a hyperlink to www.akipress.com
Our address:
Moskovskaya str. 189, Bishkek, the Kyrgyz Republic
e-mail: english@akipress.org, akipressenglish@gmail.com;
Tel/Fax: +996(312)90-07-75